PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Thrive Bioscience, Inc.

USPTO PatentsView assignee record - 30 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Thrive ranks #10,480 of 50,000 tracked US assignees by granted-patent volume, with 30 patents across 13 technology areas.

#10,480
of 50,000 US assignees by volume
Top 7%
by Innovation Score (55.8/100)
18.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R10480 · US Corporation #10,480 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,480/50,000
  • PHOTO-FINISH Technology Innovatio…
  • CPC-FOCUS C12M · 13 areas
  • INNOV-PAR 55.8/100
  • CLAIMS-RICH 18.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Technology Innovation Momentum Fund (israel) Limited Partnership (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Thrive

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Thrive Bioscience, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #10,480 of 50,000; Innovation Score 55.8/100 sits in the top 7% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Technology Innovation Momentum Fund (israel) Limited Partnership (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Thrive Bioscience, Inc. has been granted 30 US utility patents between 2020 and 2025, placing Thrive Bioscience, Inc. at #10,480 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a US Corporation, Thrive Bioscience, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Thrive sits between Technology Innovation Momentum Fund (israel) Limited Partnership (30 patents, rank #10,482) and Travel Caddy, Inc. (30 patents, rank #10,490) - the closest US assignees by grant volume. The composite Innovation Score of 55.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 30 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Thrive Bioscience, Inc.'s 18.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 13 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Thrive's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Thrive holds 30 patents at rank #10,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Thrive

By rank, the assignees closest to #10,486 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Thrive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Thrive, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Gatekeeper Systems, Inc. 56 Grote Industries, Inc. 56 University Court Of The University Of St Andrews 56 Huawei Technologies Canada Co., Ltd. 56

Thrive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 202020212022202320242025 4
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Thrive Bioscience, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 3.3%
2021 4 13.3%
2022 4 13.3%
2023 7 23.3%
2024 10 33.3%
2025partial year 4 13.3%

Which technologies does Thrive Bioscience, Inc. patent most?

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#10,480

of 50,000 tracked assignees

Innovation Score

55.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.